Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis.
Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis.
复制标题
DOI:
10.1126/scitranslmed.add2376
复制
发表时间:
2022-09-21
影响因子:
17.1
通讯作者:
Csanyi, Gabor
中科院分区:
文献类型:
--
作者:
Lin, Hui-Ping;Singla, Bhupesh;Ahn, WonMo;Ghoshal, Pushpankur;Blahove, Maria;Cherian-Shaw, Mary;Chen, Alex;Haller, April;Hui, David Y.;Dong, Kunzhe;Zhou, Jiliang;White, Joseph;Stranahan, Alexis M.;Jasztal, Agnieszka;Lucas, Rudolf;Stansfield, Brian K.;Fulton, David;Chlopicki, Stefan;Csanyi, Gabor
Accumulation of lipid-laden foam cells in the arterial wall plays a central role in atherosclerotic lesion development, plaque progression and late-stage complications of atherosclerosis. Yet, there are still fundamental gaps in our knowledge of the underlying mechanisms leading to foam cell formation in atherosclerotic arteries. The goal of this study was to investigate the role of receptor-independent macropinocytosis in arterial lipid accumulation and pathogenesis of atherosclerosis. Here, we showed that genetic inhibition of fluid-phase macropinocytosis in myeloid cells (LysMCre+ NHE1fl/fl) and repurposing of an FDA-approved drug that inhibits macrophage macropinocytosis, substantially decrease atherosclerotic lesion development in LDL receptor-deficient and ApoE−/− mice. Stimulation of macropinocytosis using genetic (H-RASG12V) and physiologically relevant approaches promotes internalization of unmodified native (nLDL) and modified (oxLDL and acLDL) lipoproteins in both wild-type and scavenger receptor (SR) knockout (CD36−/−/SR-A−/−) macrophages. Pharmacological inhibition of macropinocytosis in hypercholesterolemic wild-type and CD36−/−/SR-A−/− mice identifies an important role of macropinocytosis in LDL uptake by lesional macrophages in vivo and development of atherosclerosis. Furthermore, serial section high-resolution imaging, LDL immunolabeling and 3D reconstruction of subendothelial foam cells provide the first visual evidence of lipid macropinocytosis in both human and murine atherosclerotic arteries. In summary, our findings complement the SR paradigm of atherosclerosis and identify an entirely new therapeutic strategy to counter the development of atherosclerosis and reduce morbidity and mortality in patients with cardiovascular disease. Macrophage macropinocytosis: an important player and key therapeutic target in atherosclerosis.
登录
查看更多内容
影响因子:
64.8
作者:
Kojima Y;Volkmer JP;McKenna K;Civelek M;Lusis AJ;Miller CL;Direnzo D;Nanda V;Ye J;Connolly AJ;Schadt EE;Quertermous T;Betancur P;Maegdefessel L;Matic LP;Hedin U;Weissman IL;Leeper NJ
通讯作者:
Leeper NJ
影响因子:
6.2
作者:
Begum G;Song S;Wang S;Zhao H;Bhuiyan MIH;Li E;Nepomuceno R;Ye Q;Sun M;Calderon MJ;Stolz DB;St Croix C;Watkins SC;Chen Y;He P;Shull GE;Sun D
通讯作者:
Sun D
影响因子:
2.3
作者:
Gajda M;Jasztal A;Banasik T;Jasek-Gajda E;Chlopicki S
通讯作者:
Chlopicki S
影响因子:
6.6
作者:
Ghoshal, Pushpankur;Singla, Bhupesh;Csanyi, Gabor
通讯作者:
Csanyi, Gabor
影响因子:
15.9
作者:
Febbraio, M;Podrez, EA;Silverstein, RL
通讯作者:
Silverstein, RL